Drug Report History #5341
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v27-FR | Version v9-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated (Changed) | Updated to: 2018-02-02 | Was: 2017-06-29 |
| Drug Identification Number | 02196026 | 02196026 |
| Brand name | MYLAN-FAMOTIDINE | MYLAN-FAMOTIDINE |
| Common or Proper name (Changed) | Updated to: FAMOTIDINE | Was: Famotidine |
| Company Name | MYLAN PHARMACEUTICALS ULC | MYLAN PHARMACEUTICALS ULC |
| Ingredients | FAMOTIDINE | FAMOTIDINE |
| Strength(s) | 40MG | 40MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size (Changed) | Updated to: 100BT | Was: 100 |
| Additional packaging sizes | ||
| ATC code | A02BA | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date (Changed) | Updated to: 2018-01-08 | Was: 2017-07-20 |
| Actual start date (Changed) | Updated to: 2018-01-03 | Was: |
| Estimated end date (Changed) | Updated to: 2018-02-01 | Was: Unknown |
| Actual end date (Changed) | Updated to: 2018-02-01 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Last lot 3077013 Expires 30-Jun-19 | Was: |
| Health Canada comments |